{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:35:41Z","timestamp":1785454541466,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004888","name":"Illinois Department of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5NU58DP006344"],"award-info":[{"award-number":["5NU58DP006344"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jtct.2022.09.013","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T04:31:38Z","timestamp":1663993898000},"page":"860.e1-860.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of Subsequent Malignant Neoplasms Following Hematopoietic Stem Cell Transplantation with Total Body Irradiation or Total Marrow Irradiation: Insights from Early Follow-Up"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-3415","authenticated-orcid":false,"given":"Colton","family":"Ladbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-8603","authenticated-orcid":false,"given":"Saro","family":"Armenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-5699","authenticated-orcid":false,"given":"Alysia","family":"Bosworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-5017","authenticated-orcid":false,"given":"F. Lennie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Dandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monzr","family":"Al Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.09.013_bib0001","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bmt.1700933","article-title":"Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"20","author":"van Rhee","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.09.013_bib0002","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/leu.2016.101","article-title":"Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party","volume":"30","author":"Sobh","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.09.013_bib0003","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"Zittoun","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.09.013_bib0004","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","article-title":"Acute lymphoblastic leukemia, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Brown","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2022.09.013_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","article-title":"NCCN Guidelines Insights: acute myeloid leukemia, Version 2.2021","volume":"19","author":"Pollyea","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2022.09.013_bib0006","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood.V91.6.1833","article-title":"Malignancies after hematopoietic stem cell transplantation: many questions, some answers","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.09.013_bib0007","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2011.08756.x","article-title":"Secondary cancers following allogeneic haematopoietic cell transplantation in adults","volume":"154","author":"Majhail","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0008","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation","volume":"24","author":"Leisenring","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1532\/IJH97.03178","article-title":"Second malignant neoplasms following hematopoietic stem cell transplantation","volume":"79","author":"Friedman","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1704706","article-title":"Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation","volume":"35","author":"Hasegawa","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.09.013_bib0011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2010-06-288357","article-title":"Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies","volume":"117","author":"Rosenthal","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.09.013_bib0012","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2006.10.047","article-title":"Image-guided total marrow and total lymphatic irradiation using helical tomotherapy","volume":"67","author":"Schultheiss","year":"2007","journal-title":"Int J Radiat Oncol Biol Physics."},{"key":"10.1016\/j.jtct.2022.09.013_bib0013","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/S1470-2045(20)30342-9","article-title":"Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia","volume":"21","author":"Wong","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2012.03.033","article-title":"Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"85","author":"Wong","year":"2013","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"10.1016\/j.jtct.2022.09.013_bib0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.09.013_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2008.04.071","article-title":"Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation","volume":"73","author":"Wong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2022.09.013_bib0017","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2019.08.010","article-title":"Radiation-related toxicities using organ sparing total marrow irradiation transplant conditioning regimens","volume":"105","author":"Shinde","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2022.09.013_bib0018","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/j.prro.2020.03.006","article-title":"Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatments","volume":"10","author":"Han","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0019","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/cam4.3896","article-title":"Late-occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors","volume":"10","author":"Sy","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtct.2022.09.013_bib0020","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.20.02401","article-title":"Atrial fibrillation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"39","author":"Chang","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0021","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jcsm.12570","article-title":"Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation","volume":"11","author":"Armenian","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jtct.2022.09.013_bib0022","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/jnci\/djaa022","article-title":"Conditional survival, cause-specific mortality, and risk factors of late mortality after allogeneic hematopoietic cell transplantation","volume":"112","author":"Wong","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2022.09.013_bib0023","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed\/refractory acute leukemia","volume":"23","author":"Stein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.09.013_bib0024","first-page":"4607","article-title":"A phase II study of total marrow and lymphoid irradiation (TMLI) in combination with cyclophosphamide and etoposide in patients with relapsed\/refractory acute leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"130","author":"Stein","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.09.013_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total body irradiation: guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2022.09.013_bib0026","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.critrevonc.2005.03.014","article-title":"Secondary malignancies after hematopoietic stem cell transplantation","volume":"56","author":"Ghelani","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0027","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/02841869409121767","article-title":"Secondary malignancies following cancer chemotherapy","volume":"33","author":"Boffetta","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0028","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0889-8588(18)30249-1","article-title":"Risk factors for the development of secondary malignancies after marrow transplantation","volume":"7","author":"Deeg","year":"1993","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jtct.2022.09.013_bib0029","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3857\/roj.2018.00290","article-title":"Radiation induced secondary malignancies: a review article","volume":"36","author":"Dracham","year":"2018","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.jtct.2022.09.013_bib0030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2001.19.2.464","article-title":"Solid cancers after bone marrow transplantation","volume":"19","author":"Bhatia","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0031","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM198909213211203","article-title":"Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia","volume":"321","author":"Witherspoon","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.09.013_bib0032","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.09.013_bib0033","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","article-title":"New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors","volume":"21","author":"Baker","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.09.013_bib0034","doi-asserted-by":"crossref","first-page":"367.e1","DOI":"10.1016\/j.jtct.2022.04.022","article-title":"Long-term follow-up of multiple myeloma patients treated with tandem autologous transplantation following melphalan and upon recovery, total marrow irradiation","volume":"28","author":"Ladbury","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.09.013_bib0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41409-018-0290-6","article-title":"Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single-centre cohort with a long follow-up","volume":"54","author":"Martelin","year":"2019","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722016335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722016335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:06:54Z","timestamp":1763003214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722016335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2666636722016335"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.09.013","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Subsequent Malignant Neoplasms Following Hematopoietic Stem Cell Transplantation with Total Body Irradiation or Total Marrow Irradiation: Insights from Early Follow-Up","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}